COVID-19

For more information on COVID-19 and the visitor restrictions in place at Capital Health, click here.
For information on our advanced safety measures for receiving care during the COVID-19 pandemic, click here.

Can we help you find something?

Can we help you find something?

Clinical Trials

Neuro-Oncology Clinical Research

The Center for Neuro-Oncology participates in, and develops, numerous research studies and clinical trials. The goal is to help provide greater understanding, develop new methods to detect and diagnose those diseases, and focus on innovative treatments that are not broadly available to patients.

Clinical trials offer patients some of the very latest in care while giving physicians and researchers the opportunity to study the safety and effectiveness of new treatments. Participation is voluntary.

Our experienced neuro-oncology team, carefully review study criteria, potential benefits, risks, and other considerations with eligible patients for enrollment into a clinical study. Once enrolled, our clinical research staff carefully monitors patients throughout the research trial and is available to answer questions.

To learn more about our ongoing trials available at the Center for Neuro-Oncology, please contact our nurse at 877-601-6282.

Glioblastoma Multiforme (Newly Diagnosed and Recurrent) and Anaplastic Astrocytoma (Newly Diagnosed and Recurrent)

3D-Prediction of Patient-Specific Response (3D-PREDICT) – Glioblastoma Multiforme

PI: Dr. Navid Redjal
Sponsor: Kiyatec

Meningioma

Observation or Radiation Therapy in Treating Patients with Newly Diagnosed Grade II Meningioma that has been Completely Removed by Surgery (NRG- BN003)

PI: Dr. Navid Redjal
Co-I: Drs. Timothy Chen and Shirnett Williamson
Sponsor: NRG-NCI

Malignant Brain Tumors (including metastatic brain tumors and gliomas)

Molecular and Biochemical Characterization of Malignant Brain Tumors

The purpose of this research is to analyze and collect brain tumor tissue to help further molecularly and biochemically characterize these lesions to help better understand this disease and, ultimately, add to the scientific data to help find new and effective treatments.

PI: Dr. Navid Redjal
Co-I: Dr. Joshua Rabinowitz, Princeton University
Sponsor: Capital Health

OS and PFS after Neuro Oncological Surgery with or without Radiation Therapy

Assess current trends and quality of life outcomes in utilization of SRS (Stereotactic Radiosurgery) and WBRT (Whole Brain Radiation Therapy) in adult brain tumor patients.

PI: Dr. Navid Redjal
Co-I: Drs. Timothy Chen and Shirnett Williamson
Sponsor: Capital Health

Capital Health Becomes Region’s First Center of Excellence in Robotic Surgery

In August, Capital Health Medical Center- Hopewell was designated a Center of Excellence in Robotic Surgery by Surgical Review Corporation (SRC). The Center of Excellence accreditation distinguishes Capital Health as having met rigorous, internationally recognized standards in providing the safest, highest quality of care and surgical capabilities.

 

Capital Health earns LGBTQ Health Care Equality Leader Designation in Human Rights Campaign Foundation’s Healthcare Equality Index

“Capital Health’s designation as an LGBTQ Health Care Equality Leader affirms our commitment to diversity, equity and inclusion in the care we deliver to our patients, our relationship with the communities we serve and the support we provide for our employees.” -- Dr. Eric Schwartz, vice president of Community Health and Transformation and executive director of Capital Health’s Institute for Urban Care

Capital Health Moves Primary Care Office to New Location in Yardley

Capital Health Primary Care – Langhorne, part of Capital Health Medical Group and a trusted provider of primary care for children and adults in Bucks County, Pennsylvania, has moved to a new location at 1690 Big Oak Road in Yardley. As a result of the move, the name of the practice has changed to Capital Health Primary Care – Yardley.

View All News
View All Events